Cargando…

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma

IMPORTANCE: Cancer treatment can result in burdensome toxic effects that profoundly affect patient quality of life. In seeking to emphasize the efficacy of tested treatments, clinical trial reports may use subjective or minimizing terms to describe adverse events (AEs). OBJECTIVE: To evaluate patter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Najjar, Mimi, McCarron, John, Cliff, Edward R. Scheffer, Berger, Katherine, Steensma, David P., Al Hadidi, Samer, Chakraborty, Rajshekhar, Goodman, Aaron, Anto, Eric, Greene, Tom, Sborov, Douglas, Mohyuddin, Ghulam Rehman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638643/ https://www.ncbi.nlm.nih.gov/pubmed/37948080 http://dx.doi.org/10.1001/jamanetworkopen.2023.42195

Ejemplares similares

Is aggressive treatment of smoldering myeloma the path to curing myeloma?
por: Chakraborty, Rajshekhar, et al.
Publicado: (2023)

Clinician preferences on treatment of smoldering myeloma: a cross-sectional survey
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2023)

Characteristics of measurable residual disease assessment in myeloma: a review of clinical trials from 2015–2020
por: Van Oekelen, Oliver, et al.
Publicado: (2022)

The Landscape of Currently Enrolling Maintenance Trials in Multiple Myeloma
por: Tariq, Syed Maaz, et al.
Publicado: (2023)

Reporting of Postprotocol Therapies and Attrition in Multiple Myeloma Randomized Clinical Trials: A Systematic Review
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2021)

Global Myeloma Trial Participation and Drug Access in the Era of Novel Therapies
por: Fatoki, Raleigh Ayoolu, et al.
Publicado: (2022)

Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2022)

Hospitalization at the end of life in patients with multiple myeloma
por: Abbasi, Saqib, et al.
Publicado: (2021)

Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis
por: Reynolds, Gemma, et al.
Publicado: (2023)

P1518: INFECTIONS FOLLOWING BISPECIFIC ANTIBODIES IN MYELOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Reynolds, Gemma, et al.
Publicado: (2023)

Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic review
por: Ali, Mohammad O., et al.
Publicado: (2023)

Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
por: Gil, Kellen, et al.
Publicado: (2022)

Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study
por: McCurdy, Arleigh, et al.
Publicado: (2023)

Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma
por: Alqazaqi, Raghad, et al.
Publicado: (2022)

National Comprehensive Cancer Network Guideline Recommendations of Cancer Drugs With Accelerated Approval
por: Cliff, Edward R. Scheffer, et al.
Publicado: (2023)

Immunoglobulin D Multiple Myeloma Presenting as Spontaneous Fracture
por: Al Hadidi, Samer, et al.
Publicado: (2017)

Financial toxicity in hematological malignancies: a systematic review
por: Ouchveridze, Evguenia, et al.
Publicado: (2022)

Primary Myelofibrosis Presenting as Extramedullary Hematopoiesis in a Transplanted Liver Graft: Case Report and Review of the Literature
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2016)

A Rare Presentation of a Rare Disease: Pulmonary Lymphomatoid Granulomatosis
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2012)

Differential Diagnosis and Therapeutic Advances in Multiple Myeloma: A Review Article
por: Hussain, Munawwar, et al.
Publicado: (2023)

A Rare Cause of Hemophagocytic Lymphohistiocytosis: Fusobacterium Infection—A Case Report and Review of the Literature
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2016)

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
por: Shrivastava, Trilok, et al.
Publicado: (2023)

Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor–T Cell Therapy for Hematological Malignant Neoplasms
por: Al Hadidi, Samer, et al.
Publicado: (2022)

Gender disparities in multiple myeloma publications
por: Dweik, Aala, et al.
Publicado: (2022)

Applying the Principles of Bloom’s Taxonomy to Managing Tachyarrhythmia: Results of a Tachyarrhythmia Workshop
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2019)

Does Use of High-fidelity Simulation Improve Resident Physician Competency and Comfort Identifying and Managing Bradyarrhythmias?
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2020)

Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease
por: Abdallah, Al‐Ola, et al.
Publicado: (2021)

Health Disparities Experienced by Hispanic Americans with Multiple Myeloma: A Systematic Review
por: Anampa-Guzmán, Andrea, et al.
Publicado: (2022)

Arterial thromboembolism in multiple myeloma in the context of modern anti-myeloma therapy
por: Chakraborty, Rajshekhar, et al.
Publicado: (2021)

Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019
por: Balmaceda, Nicole, et al.
Publicado: (2021)

Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma
por: Al Hadidi, Samer, et al.
Publicado: (2023)

Toxicity management strategies for next-generation novel therapeutics in multiple myeloma
por: Steinbach, Mary, et al.
Publicado: (2022)

Afatinib-induced Interstitial Lung Disease Successfully Treated with Corticosteroids: Case Report and Review of the Literature
por: Jobe, Amanda L, et al.
Publicado: (2018)

Reducing Resident Physician Workload to Improve Well Being
por: Al-kofahi, Mejalli, et al.
Publicado: (2019)

Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
por: Sengar, Manju, et al.
Publicado: (2023)

The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review
por: Al Shuhaimi, Lamya, et al.
Publicado: (2022)

Accurate Allele Frequencies from Ultra-low Coverage Pool-Seq Samples in Evolve-and-Resequence Experiments
por: Tilk, Susanne, et al.
Publicado: (2019)

Implementation of an Audience Response System in a Case Conference Curriculum: Results of a Placebo-Controlled Trial
por: Mohyuddin, Ghulam Rehman, et al.
Publicado: (2021)

Characterisation of Hybrid Photon Detectors for the LHCb and an analysis of the rare decay $B_{s}^{o} \rightarrow \phi \phi$
por: McCarron, J
Publicado: (2008)

Slow and steady wins the race: Optimizing lentiviral vector production for efficient clinical-scale manufacturing
por: McCarron, Alexandra
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_elrbo56t8ud8dgvqcidd3ntm9k